1. 1138PDFirst in human study with GSK3359609 [GSK609], inducible T cell co-stimulator (ICOS) receptor agonist in patients [Pts] with advanced, solid tumors: Preliminary results from INDUCE-1. (23rd October 2018) Authors: Hansen, A; Bauer, T M; Moreno, V; Maio, M; Groenland, S; Martin-Liberal, J; Gan, H; Rischin, D; Millward, M; Olszanski, A J; Cho, D C; Paul, E; Ballas, M; Ellis, C; Zhou, H; Yadavilli, S; Sadik Shaik, J; Schmidt, E V; Hoos, A; Angevin, E Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1192PEvaluation of OX40 receptor density, influence of IgG Isotype and dosing paradigm in anti-OX40-mediated efficacy and biomarker responses with PD-1 blockade. (23rd October 2018) Authors: Jackson, H; Bhattacharya, S; Bojczuk, P; Kilian, D; Seestaller Wehr, L; Hahn, A; Shi, H; Bi, M; Adam, M; Jing, J; Morley, P; Hopson, C; Paul, E; Hoos, A; Smothers, J; Srinivasan, R; Yanamandra, N Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1840PPreclinical evaluation of a non-depleting, first-in-class humanized IgG4 agonist anti-ICOS antibody. (23rd October 2018) Authors: Brett, S; Yadavilli, S; Seestaller-Wehr, L; Bhattacharya, S; Jackson, H; Bi, M; Willoughby, J; Zhang, T; Liu, Y-B; Katlinskaya, Y K; Shi, H; Jing, J; Hahn, A; Speller, S; David Figueroa, D; Yu, J; Olive, D; Cragg, M; Mayes, P; Hoos, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. From adaptive licensing to adaptive pathways: Delivering a flexible life‐span approach to bring new drugs to patients. Issue 3 (4th February 2015) Authors: Eichler, H‐G; Baird, LG; Barker, R; Bloechl‐Daum, B; Børlum‐Kristensen, F; Brown, J; Chua, R; Del Signore, S; Dugan, U; Ferguson, J; Garner, S; Goettsch, W; Haigh, J; Honig, P; Hoos, A; Huckle, P; Kondo, T; Le Cam, Y; Leufkens, H; Lim, R Journal: Clinical pharmacology & therapeutics Issue: Volume 97:Issue 3(2015:Mar.) Page Start: 234 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. From adaptive licensing to adaptive pathways: Delivering a flexible life‐span approach to bring new drugs to patients. Issue 3 (4th February 2015) Authors: Eichler, H‐G; Baird, LG; Barker, R; Bloechl‐Daum, B; Børlum‐Kristensen, F; Brown, J; Chua, R; Del Signore, S; Dugan, U; Ferguson, J; Garner, S; Goettsch, W; Haigh, J; Honig, P; Hoos, A; Huckle, P; Kondo, T; Le Cam, Y; Leufkens, H; Lim, R Journal: Clinical pharmacology & therapeutics Issue: Volume 97:Issue 3(2015:Mar.) Page Start: 234 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Pharmaceuticals Licensing and Reimbursement in the European Union, United States, and Japan. Issue 6 (17th October 2016) Authors: Oye, KA; Eichler, HG; Hoos, A; Mori, Y; Mullin, TM; Pearson, M Journal: Clinical pharmacology & therapeutics Issue: Volume 100:Issue 6(2016:Dec.) Page Start: 626 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗